|
related topics |
{stock, price, share} |
{provision, law, control} |
{personnel, key, retain} |
{regulation, change, law} |
{product, liability, claim} |
{capital, credit, financial} |
{interest, director, officer} |
{control, financial, internal} |
{condition, economic, financial} |
{debt, indebtedness, cash} |
{stock, price, operating} |
|
We have a history of large operating losses.
We may need additional capital to meet our working capital requirements and debt service and will be required to curtail our operations if it is not available.
Revenue from our Cosmedicine line of products may not grow quickly enough to meet working capital and debt service requirements.
We have only one supplier for our Cosmedicine products.
We are dependent on our relationships with Sephora and HSN
We may be negatively affected by the recent Chapter 11 Filing by GK Acquisition
The demand for our products may be adversely affected by changes in the economy.
We depend on our senior management and key employees, the loss of which could adversely affect our operations.
Government regulation may affect our ability to carry out our business plan and may change from time to time.
We are subject to regulation by the FDA.
We are subject to regulation by Federal Trade Commission.
Plans to increase the authorized number of shares could have an adverse effect on the market value of our Common Stock.
Certain provisions of our charter documents and Delaware law could discourage potential acquisition proposals and could deter, delay or prevent a change in control of our company that our stockholders consider favorable and could depress the market value of our Common Stock.
Future sales of our Common Stock could depress our market price and diminish the value of your investment
There could be a change in control of the Company if Laurus was to exercise enough of its outstanding Common Stock warrants after the Company completes its planned Authorized Share Increase.
Our Common Stock price could be volatile, which could result in substantial losses for investors.
Because our shares are deemed penny stocks, you may have difficulty selling them in the secondary trading market.
Full 10-K form ▸
|
|
related documents |
754811--9/10/2009--U_S_GLOBAL_INVESTORS_INC |
1425883--4/2/2009--Independent_Film_Development_CORP |
769592--6/27/2008--MOBILEPRO_CORP |
923139--3/16/2009--FLUSHING_FINANCIAL_CORP |
1292026--3/31/2010--Odimo_INC |
1396633--4/15/2009--Castwell_Precast_CORP |
1367617--9/12/2008--CYBERMESH_INTERNATIONAL_CORP. |
1358099--3/25/2009--ROYAL_EQUINE_ALLIANCE_CORP |
1292026--4/2/2007--Odimo_INC |
1182011--12/15/2010--FORCE_FUELS_INC. |
1070680--3/29/2010--CENTRAL_FEDERAL_CORP |
1083706--6/27/2008--ENXNET_INC |
746834--3/13/2006--NGAS_Resources_Inc |
731859--4/2/2007--AMPAL-AMERICAN_ISRAEL_CORP |
1398702--3/29/2010--TECKMINE_INDUSTRIES_INC. |
1323639--3/31/2008--180_Connect_Inc. |
857953--4/11/2006--JMAR_TECHNOLOGIES_INC |
829117--4/10/2009--SAFE_TECHNOLOGIES_INTERNATIONAL_INC |
723646--3/15/2007--FRANKLIN_FINANCIAL_SERVICES_CORP_/PA/ |
1380856--11/12/2008--APRECIA_INC |
778438--3/6/2006--BERRY_PETROLEUM_CO |
351017--3/27/2008--AUTOINFO_INC |
351017--3/23/2009--AUTOINFO_INC |
1021917--10/13/2009--ASPEON_INC |
723646--3/13/2006--FRANKLIN_FINANCIAL_SERVICES_CORP_/PA/ |
1140657--3/26/2008--HUNTINGTON_PREFERRED_CAPITAL_INC |
779956--4/30/2007--FASTFUNDS_FINANCIAL_CORP |
1265840--11/12/2009--AMERICAS_WIND_ENERGY_CORP |
1387341--3/31/2008--Boatatopia |
763907--3/12/2008--FIRST_UNITED_CORP/MD/ |
|